Beam Therapeutics (BEAM) Short Interest Ratio & Short Volume $27.50 -0.44 (-1.57%) (As of 11/13/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Beam Therapeutics Short Interest DataBeam Therapeutics (BEAM) has a short interest of 12.31 million shares. This marks a 10.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.8, indicating that it would take 13.8 days of the average trading volume of 1.23 million shares to cover all short positions.Current Short Interest12,310,000 sharesPrevious Short Interest11,160,000 sharesChange Vs. Previous Month+10.30%Dollar Volume Sold Short$269.71 millionShort Interest Ratio13.8 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares82,810,000 sharesPercentage of Shares Shorted14.87%Today's Trading Volume822,497 sharesAverage Trading Volume1,233,838 sharesToday's Volume Vs. Average67% Short Selling Beam Therapeutics? Sign up to receive the latest short interest report for Beam Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBEAM Short Interest Over TimeBEAM Days to Cover Over TimeBEAM Percentage of Float Shorted Over Time Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Beam Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202412,310,000 shares $269.71 million +10.3%N/A13.8 $21.91 10/15/202411,160,000 shares $293.95 million -1.8%N/A12.6 $26.34 9/30/202411,360,000 shares $278.32 million +3.7%N/A11.8 $24.50 9/15/202410,960,000 shares $288.25 million -1.1%N/A10.3 $26.30 8/31/202411,080,000 shares $295.61 million -0.9%N/A9.2 $26.68 8/15/202411,180,000 shares $277.93 million -3.8%N/A8.9 $24.86 Get the Latest News and Ratings for BEAM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202411,620,000 shares $367.66 million -3.7%N/A8.9 $31.64 7/15/202412,060,000 shares $308.98 million +2.2%N/A8.7 $25.62 6/30/202411,800,000 shares $276.47 million -8.9%N/A8.7 $23.43 6/15/202412,950,000 shares $322.07 million -6.4%N/A9.7 $24.87 5/31/202413,830,000 shares $329.43 million -5.1%N/A11 $23.82 5/15/202414,580,000 shares $351.52 million +4.0%N/A10.2 $24.11 4/30/202414,020,000 shares $297.50 million +6.5%N/A9.3 $21.22 4/15/202413,170,000 shares $338.47 million -2.1%N/A8.4 $25.70 3/31/202413,450,000 shares $444.39 million -6.1%N/A9.7 $33.04 3/15/202414,320,000 shares $507.07 million +9.2%N/A10.1 $35.41 2/29/202413,110,000 shares $517.71 million -2.4%N/A9.2 $39.49 2/15/202413,430,000 shares $443.46 million +0.3%N/A9.6 $33.02 1/31/202413,390,000 shares $326.72 million +2.0%N/A9.7 $24.40 1/15/202413,130,000 shares $336.13 million -2.7%N/A8.7 $25.60 12/31/202313,490,000 shares $367.20 million +0.1%N/A9.4 $27.22 12/15/202313,480,000 shares $383.10 million +3.7%N/A9.5 $28.42 11/30/202313,000,000 shares $365.04 million -6.0%N/A9.8 $28.08 11/15/202313,830,000 shares $347.82 million -4.3%N/A11.1 $25.15 10/31/202314,450,000 shares $305.47 million -4.3%N/A13.6 $21.14 10/15/202315,100,000 shares $336.13 million +5.2%N/A16.3 $22.26 9/30/202314,350,000 shares $345.12 million +6.2%N/A16.5 $24.05 9/15/202313,510,000 shares $338.43 million +2.9%N/A16.1 $25.05 8/31/202313,130,000 shares $304.35 million +0.5%N/A15.8 $23.18 8/15/202313,060,000 shares $316.97 million +8.8%N/A15.8 $24.27 7/31/202312,000,000 shares $370.44 million -3.7%N/A14.1 $30.87 7/15/202312,460,000 shares $384.52 million -1.4%N/A15.1 $30.86 6/30/202312,630,000 shares $403.28 million +1.5%N/A15.3 $31.93 6/15/202312,450,000 shares $423.30 million -0.5%N/A14.6 $34.00 5/31/202312,510,000 shares $399.07 million -4.9%20.0%13.6 $31.90 5/15/202313,150,000 shares $473.27 million +3.3%21.0%13.4 $35.99 4/30/202312,730,000 shares $390.94 million -1.1%21.4%13.7 $30.71 4/15/202312,870,000 shares $402.44 million -5.4%21.7%13.8 $31.27 3/31/202313,610,000 shares $416.74 million -2.2%22.9%14.6 $30.62 3/15/202313,910,000 shares $488.24 million +11.5%23.5%15.3 $35.10War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 2/28/202312,480,000 shares $502.20 million +4.4%21.1%14.9 $40.24 2/15/202311,950,000 shares $525.08 million -3.8%20.7%15.2 $43.94 1/31/202312,420,000 shares $539.65 million -4.5%21.5%14.8 $43.45 1/15/202313,010,000 shares $562.55 million +9.0%22.6%15.6 $43.24 12/30/202211,940,000 shares $466.97 million +1.7%20.7%14.3 $39.11 12/15/202211,740,000 shares $496.72 million -5.6%20.4%13.9 $42.31 11/30/202212,440,000 shares $574.60 million -4.4%21.6%14 $46.19 11/15/202213,010,000 shares $639.83 million -0.7%22.6%13.8 $49.18 10/31/202213,100,000 shares $577.19 million +0.2%23.8%12.2 $44.06 10/15/202213,080,000 shares $594.75 million -0.3%23.8%12.2 $45.47 9/30/202213,120,000 shares $625.04 million +5.8%23.9%11.3 $47.64 9/15/202212,400,000 shares $750.08 million +2.1%22.6%10 $60.49 8/31/202212,140,000 shares $662.84 million +0.1%22.1%9.3 $54.60 8/15/202212,130,000 shares $852.86 million -6.5%22.1%9.2 $70.31 7/31/202212,970,000 shares $816.85 million -2.0%22.8%9.5 $62.98 7/15/202213,240,000 shares $762.89 million +3.4%23.3%9.5 $57.62 6/30/202212,810,000 shares $495.88 million +10.2%22.6%9.4 $38.71 6/15/202211,620,000 shares $371.26 million +4.6%20.5%8.7 $31.95 5/31/202211,110,000 shares $390.85 million -4.9%19.7%9.1 $35.18 5/15/202211,680,000 shares $414.06 million +8.1%21.7%9.9 $35.45 4/30/202210,810,000 shares $405.70 million +10.5%20.1%10.3 $37.53 4/15/20229,780,000 shares $453.79 million +10.9%18.5%9.3 $46.40 3/31/20228,820,000 shares $505.39 million +3.6%16.9%8.4 $57.30 3/15/20228,510,000 shares $470.09 million -3.6%16.3%9.1 $55.24 2/28/20228,830,000 shares $691.83 million +7.6%17.1%9.8 $78.35 2/15/20228,210,000 shares $606.47 million +4.7%15.9%9.5 $73.87 1/31/20227,840,000 shares $542.61 million +26.5%15.2%9.7 $69.21 1/15/20226,200,000 shares $420.48 million +11.3%11.5%8.8 $67.82 12/31/20215,570,000 shares $443.87 million +1.1%10.4%9.5 $79.69 12/15/20215,510,000 shares $443.72 million +5.6%10.2%9.3 $80.53 11/30/20215,220,000 shares $413.16 million +7.6%9.8%8.6 $79.15 11/15/20214,850,000 shares $419.23 million +3.9%9.1%8.1 $86.44 10/29/20214,670,000 shares $414.56 million -15.4%9.4%7.7 $88.77 10/15/20215,520,000 shares $514.13 million +9.5%11.2%8.7 $93.14 9/30/20215,040,000 shares $438.53 million -3.5%10.2%7.6 $87.01 9/15/20215,220,000 shares $533.01 million -5.6%10.6%6.3 $102.11 8/31/20215,530,000 shares $613.39 million +7.2%11.4%7 $110.92 8/13/20215,160,000 shares $521.26 million +2.8%10.8%6.5 $101.02 7/30/20215,020,000 shares $461.84 million +3.3%11.3%5.8 $92.00 7/15/20214,860,000 shares $415.77 million -9.0%10.9%5.6 $85.55 6/30/20215,340,000 shares $687.31 million -17.5%12.0%5.8 $128.71 6/15/20216,470,000 shares $572.34 million -2.1%15.0%8.1 $88.46 5/28/20216,610,000 shares $517.10 million -4.1%15.3%7.8 $78.23 5/14/20216,890,000 shares $455.70 million +4.7%15.1%6.8 $66.14 4/30/20216,580,000 shares $513.90 million -5.9%14.5%6.3 $78.10 4/15/20216,990,000 shares $534.39 million +3.0%17.6%6.5 $76.45 3/31/20216,790,000 shares $514.41 million +0.3%18.1%6.1 $75.76 3/15/20216,770,000 shares $666.30 million +17.1%18.9%5.9 $98.42 2/26/20215,780,000 shares $511.65 million +8.2%17.7%5 $88.52 2/12/20215,340,000 shares $558.88 million -4.3%16.4%5.2 $104.66War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 1/29/20215,580,000 shares $557.39 million +0.9%17.1%5.9 $99.89 1/15/20215,530,000 shares $615.60 million No Change16.8%6.1 $111.32 BEAM Short Interest - Frequently Asked Questions What is Beam Therapeutics' current short interest? Short interest is the volume of Beam Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 12,310,000 shares of BEAM short. Learn More on Beam Therapeutics' current short interest. What is a good short interest ratio for Beam Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAM shares currently have a short interest ratio of 14.0. Learn More on Beam Therapeutics's short interest ratio. Which institutional investors are shorting Beam Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Beam Therapeutics: Susquehanna International Group LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Beam Therapeutics' short interest increasing or decreasing? Beam Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 12,310,000 shares, an increase of 10.3% from the previous total of 11,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Beam Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Beam Therapeutics: Intellia Therapeutics, Inc. (15.86%), Sangamo Therapeutics, Inc. (9.12%), Editas Medicine, Inc. (20.88%), Precision BioSciences, Inc. (5.77%), AlloVir, Inc. (3.42%), Repligen Co. (6.33%), Halozyme Therapeutics, Inc. (8.14%), Arcellx, Inc. (9.74%), Krystal Biotech, Inc. (12.00%), ADMA Biologics, Inc. (6.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Beam Therapeutics stock? Short selling BEAM is an investing strategy that aims to generate trading profit from Beam Therapeutics as its price is falling. BEAM shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Beam Therapeutics? A short squeeze for Beam Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAM, which in turn drives the price of the stock up even further. How often is Beam Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAM, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies NTLA Short Interest Data SGMO Short Interest Data EDIT Short Interest Data DTIL Short Interest Data ALVR Short Interest Data RGEN Short Interest Data HALO Short Interest Data ACLX Short Interest Data KRYS Short Interest Data ADMA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BEAM) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BEAM Stock Alerts